follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      HomeAuthorsAnkit Singhania

      Articles by Ankit Singhania

      Ankit Singhania
      Based in India, Ankit is a financial content writer and stock market analyst. He has worked for almost a decade on several financial projects related to the stock market news, fundamental research and technical analysis for several websites. He obtained his Masters Degree In finance (MS – finance) from ICFAI. Currently, he serves as a financial consultant and technical analyst at Tradersinsights.com.
      RYTM stock
      Biotechnology

      RYTM Stock Jumps on Impressive Setmelanotide Data

      Aug 7 Ankit Singhania
      RYTM stock is making a solid move after Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) announced positive results from two Phase 3 clinical trials evaluating setmelanotide. Key Development When biotech companies receive positive news with regards to any ... [Read]
      DF stock
      Consumer Packaged Goods

      DF Stock Slumps 25%: Dean Foods Posts Weak Q2 Results

      Aug 6 Ankit Singhania
      DF stock is one of the biggest losers on Tuesday after Dean Foods Company (NYSE:DF) reported worse than expected loss for the second quarter. Another Setback Texas-based milk and dairy products company Dean Foods has ... [Read]
      CLDR stock
      Application Software

      CLDR Stock Makes Big Move Following Carl Icahn’s Surprise Stake

      Aug 2 Ankit Singhania
      CLDR stock is moving up in Friday’s session after activist investor Carl Icahn disclosed a notable stake in Cloudera Inc (NYSE:CLDR). Investors Cheer the News When a well known successful investor buys a significant stake ... [Read]
      Fitbit stock
      Computer Hardware

      Fitbit Stock Tumbles to New Low on Poor Guidance

      Aug 1 Ankit Singhania
      Fitbit stock is having the worst day in the past three years after Fitbit Inc (NYSE:FIT) trimmed its third-quarter and full-year earnings forecast. Major Setback The maker of wearable devices, Fitbit, has been fluctuating for ... [Read]
      GPRO stock
      Computer Hardware

      GPRO Stock: How are Things Looking for GoPro?

      Jul 31 Ankit Singhania
      GPRO stock has been trading within a narrow range over the past couple of months. Let’s review the business performance of GoPro Inc (NASDAQ:GPRO) to see what’s going on. Business Analysis GoPro has managed to ... [Read]
      EFOI stock
      Manufacturing - Apparel & Furniture

      EFOI Stock Flies 65% on a Major Order: Investor Excitement Picks Up

      Jul 30 Ankit Singhania
      EFOI stock is getting special attention this morning after Energy Focus Inc (NASDAQ:EFOI) announced that it has been awarded a new contract worth $3 million to supply LED solutions. Major Order Ohio-based company Energy Focus ... [Read]
      XELA stock
      Application Software

      XELA Stock Extends Rally on Appointment of New Director

      Jul 29 Ankit Singhania
      Texas-based business process automation company Exela Technologies Inc (NASDAQ:XELA) has been on an excellent run over the past few days, and today, XELA stock rose by 10% again after the company announced a key appointment ... [Read]
      SLDB stock
      Drug Manufacturers

      SLDB Stock Flies on Private Placement Worth $60 Million

      Jul 26 Ankit Singhania
      SLDB stock is one of the biggest percentage gainers on the Nasdaq after Solid Biosciences Inc (NASDAQ:SLDB) announced a $60 million private placement with new and existing investors. Solid Boost Massachusetts-based Solid Biosciences Inc made ... [Read]
      MYSZ stock
      Application Software

      MYSZ Stock Soars 50% on License Agreement with Penti

      Jul 25 Ankit Singhania
      MYSZ stock is one of the biggest penny stock gainers in Thursday’s session as investors are cheering My Size, Inc. (NASDAQ:MYSZ) after it signed a license agreement with Penti for smart measurement application MySizeID. A ... [Read]
      JNCE stock
      Biotechnology

      JNCE Stock Gains 25% After Updated Collaboration with Celgene

      Jul 24 Ankit Singhania
      JNCE stock is moving up sharply following an update from Jounce Therapeutics (NASDAQ:JNCE) regarding its partnership with Celgene (NASDAQ:CELG). Investors Cheer the News Manufacturing of predictive biomarkers and immunotherapies is big business in the biotech ... [Read]

      Posts pagination

      « 1 … 18 19 20 … 27 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Subscribe & Get FREE Rhythm Pharmaceuticals Email Alerts
      Get FREE Rhythm Pharmaceuticals Email Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      x